Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Mei Pharma Inc (NQ: MEIP ) 2.840 -0.060 (-2.07%) Streaming Delayed Price Updated: 3:59 PM EDT, Jul 15, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Mei Pharma Inc < Previous 1 2 3 4 5 6 7 Next > Stocks That Hit 52-Week Lows On Tuesday May 17, 2022 On Tuesday, 123 stocks made new 52-week lows. Via Benzinga Stocks That Hit 52-Week Lows On Friday March 25, 2022 On Friday, 166 companies set new 52-week lows. Points of Interest From Today's 52-Week Lows: The largest company by market cap to set a new 52-week low was... Via Benzinga INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of MEI Pharma, Inc. (MEIP) on Behalf of Investors May 17, 2022 From Law Offices of Howard G. Smith Via Business Wire INVESTIGATION REMINDER: The Schall Law Firm Encourages Investors in MEI Pharma, Inc. with Losses of $100,000 to Contact the Firm May 17, 2022 From The Schall Law Firm Via Business Wire MEI Pharma to Present at the H.C. Wainwright Global Investment Conference 2022 May 17, 2022 From MEI Pharma, Inc. Via Business Wire The Law Offices of Frank R. Cruz Announces Investigation of MEI Pharma, Inc. (MEIP) on Behalf of Investors May 16, 2022 From The Law Offices of Frank R. Cruz Via Business Wire INVESTIGATION ALERT: The Schall Law Firm Encourages Investors in MEI Pharma, Inc. with Losses of $100,000 to Contact the Firm May 16, 2022 From The Schall Law Firm Via Business Wire Rosen Law Firm Encourages MEI Pharma, Inc. Investors with Losses to Inquire About Class Action Investigation – MEIP May 16, 2022 From Rosen Law Firm Via Business Wire MEI Pharma and Kyowa Kirin Announce Acceptance of Two Abstracts for Presentation at the European Hematology Association 2022 Hybrid Congress May 12, 2022 From MEI Pharma, Inc. Via Business Wire MEI Pharma Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) May 02, 2022 From MEI Pharma, Inc. Via Business Wire The Daily Biotech Pulse: GlaxoSmithKline And Halozyme Go Shopping, Mylan's Insulin Glargine Recall, Turning Point Shares Lung Cancer Data And More April 13, 2022 Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus Halozyme Buys Specialty Product Company Antares In $960M Deal Via Benzinga MEI Pharma Announces Two Presentations at the American Association for Cancer Research Annual Meeting 2022 April 08, 2022 From MEI Pharma, Inc. Via Business Wire MEI Pharma Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) April 01, 2022 From MEI Pharma, Inc. Via Business Wire Analyzing Mei Pharma Inc's Short Interest March 28, 2022 Mei Pharma Inc's (NASDAQ:MEIP) short percent of float has risen 10.86% since its last report. The company recently reported that it has 7.31 million shares sold short, which is 6.... Via Benzinga Expert Ratings For MEI Pharma March 25, 2022 Analysts have provided the following ratings for MEI Pharma (NASDAQ:MEIP) within the last quarter: Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total... Via Benzinga Mid-Afternoon Market Update: Dow Falls 30 Points; Cutera Shares Spike Higher March 25, 2022 U.S. stocks traded lower toward the end of trading, with the Nasdaq Composite dropping more than 100 points on Friday. The Dow traded down 0.09% to 34,677.25 while the NASDAQ fell... Via Benzinga Stocks That Hit 52-Week Lows On Monday March 28, 2022 On Monday, 147 stocks hit new 52-week lows. Areas of Significance In Today's 52-Week Lows: The largest company by market cap to set a new 52-week low was... Via Benzinga 64 Biggest Movers From Friday March 28, 2022 Gainers Clever Leaves Holdings Inc. (NASDAQ: CLVR) shares surged 143% to settle at $3.84 on Friday after the company reported better-than-expected Q4 sales results and reaffirmed... Via Benzinga Analysts Cut Price Target On MEI Pharma As Stock Falls To 52-Week Low After Zandelisib Update March 25, 2022 The FDA crushed MEI Pharma Inc's (NASDAQ: MEIP) hopes of winning accelerated approval for its PI3K inhibitor, zandelisib, on the strength of phase 2 data. In the... Via Benzinga 12 Health Care Stocks Moving In Friday's Intraday Session March 25, 2022 Via Benzinga Mid-Day Market Update: Nasdaq Down 1%; Icosavax Shares Plummet March 25, 2022 U.S. stocks pared gains midway through trading, with the Nasdaq Composite dropping 1% on Friday. The Dow traded up 0.02% to 34,715.99 while the NASDAQ fell 1.02% to 14,045.00... Via Benzinga 36 Stocks Moving In Friday's Mid-Day Session March 25, 2022 Gainers Forge Global Holdings, Inc. (NYSE: FRGE) shares jumped 66.4% to $20.70. Clever Leaves Holdings Inc. (NASDAQ: CLVR) jumped 29.1% to $2.04 after the company reported... Via Benzinga Futures Ramp To Session High As Oil Slides March 25, 2022 S&P futures were near session highs, up 0.3% or 14 points to 4,526 around the time US traders got to their desks as investors evaluated economic risks from Federal Reserve monetary-policy tightening... Via Talk Markets Penny Stocks Today: Why MEIP and HNST Are Plunging Friday March 25, 2022 We're checking in on the latest penny stocks news for today with two companies that investors are watching fall on Friday! Via InvestorPlace Benzinga's Top Ratings Upgrades, Downgrades For March 25, 2022 March 25, 2022 Upgrades For Aris Water Solutions Inc (NYSE:ARIS), Capital One upgraded the previous rating of Equal-Weight to Overweight. The stock has a 52-week-high of $19.16 and a 52-week-low... Via Benzinga 12 Health Care Stocks Moving In Friday's Pre-Market Session March 25, 2022 Gainers Tilray Brands (NASDAQ:TLRY) stock increased by 17.2% to $8.17 during Friday's pre-market session. The company's market cap stands at $3.9 billion. Sundial... Via Benzinga The Daily Biotech Pulse: MEI Pharma Wilts On Adverse Regulatory Development, Decision Day For Zogenix, AN2 Therapeutics IPO March 25, 2022 Here's a roundup of top developments in the biotech space over the last 24 hours. Via Benzinga 10 Biggest Price Target Changes For Friday March 25, 2022 Jefferies cut the price target on MEI Pharma, Inc. (NASDAQ: MEIP) from $4 to $1. MEI Pharma shares fell 44.2% to $1.01 in pre-market trading. Via Benzinga Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday March 25, 2022 Good morning, trader! Get ready for one more busy day of investing today with the biggest pre-market stock movers for Friday! Via InvestorPlace 34 Stocks Moving in Friday's Pre-Market Session March 25, 2022 Gainers Clever Leaves Holdings Inc. (NASDAQ: CLVR) rose 40.5% to $2.22 in pre-market trading after the company reported better-than-expected Q4 sales results and reaffirmed FY22... Via Benzinga < Previous 1 2 3 4 5 6 7 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.